President Obama’s Deputy Drug Czar Tom McClellan Comments in USA TODAY Article; Endorses Non-Smoked Medical Marijuana Delivery Systems Identical to the First Product Cannabis Science is Developin

 

http://www.usatoday.com/news/nation/2010-03-08-marijuana_N.htm

 

 

PlantTheLand

President Obama’s Deputy Drug Czar Tom McClellan Comments in USA TODAY Article; Endorses Non-Smoked Medical Marijuana Delivery Systems Identical to the First Product Cannabis Science is Developin
More News related to CBIS
* President Obama’s Deputy Drug Czar Tom McClellan Comments in USA TODAY Article; Endorses Non-Smoked Medical Marijuana Delivery Systems Identical to the First Product Cannabis Science is Developin
* Highly Specialized International FDA Regulatory Compliance Firm Signs With Cannabis Science to Prepare for Company’s First Pre-Investigative New Drug (IND) Submission Package for Veterans PTSD Pr
* Cannabis Science Sets Second FDA Drug Target on $20 Billion "Chronic Pain" Market Targeting the Huge Need for Safe Non-Addictive Non-Lethal Cannabis Based Medications
* Cannabis Science Officially Begins Its First Pre-IND FDA Application Process for Post Traumatic Stress Disorder (PTSD)
* Cannabis Science Officially Begins Its First Pre-IND FDA Application Process For Post Traumatic Stress Disorder (PTSD)
More News related to CBIS
More News related to Press Releases
* A.M. Best Posts Video, Transcript of Webinar on the State of the Market for Protection & Indemnity Clubs
* Kendall Law Group Investigates Facet Biotech Corporation Merger for Shareholders
* NoteVault Announces Release of Its iPhone Speech to Text Solution for Construction and Engineering Firms
* KIKA Clinical Solutions Announces Veracity(TM) 3.8, Newest Version of its Advanced EDC Solution for Pharmaceutical, Biotechnology and Medical Device Clinical Trial Management
* Human Resources Expert Joins Burrill & Company
More News related to Press Releases
March 10, 2010 12:30 PM EST
COLORADO SPRINGS, Colo., March 10, 2010 (GLOBE NEWSWIRE) — Cannabis Science, Inc. (OTCBB: CBIS), a pioneering US pharmaceutical cannabis company, notes that comments by President Obama’s Deputy Director of the White House Office of National Drug Control Policy, Tom McClellan, in yesterday’s USA TODAY pinpoints the need for non-smoked medical cannabis products similar to those currently being developed for FDA clinical trials by Cannabis Science.
Deputy Director McClellan said in the article that Obama administration still opposes smoking marijuana for its medicinal benefit. As well, he says more research is needed to deliver the medically useful ingredients in a non-smoked form. He then went on to say, "We have the safest medications in the world and it’s not a coincidence. We have an enviable process by which we approve medications, and that’s through the FDA (Food and Drug Administration)."
Dr. Robert Melamede, President and CEO of Cannabis Science, "With an open invitation like this from the Obama Administration, we at Cannabis Science feel more confident than ever that our efforts to provide our "wounded warriors" with an alternative to treatments that are not working will be fairly examined, when we submit our non-smoked cannabis pharmaceutical products to the FDA for clinical trials. We are doing precisely the sort of scientific research that Deputy Director McClellan is calling for."
Richard Cowan, Cannabis Science CFO and a former CEO of the National Organization for the Reform of Marijuana Laws (NORML), noted, "It is important that the Obama Administration is making such an open call that they want more FDA clinical trial research on the same types of drugs we are creating. Consequently, we will rapidly proceed with our development of a cannabis-based medicine for PTSD for FDA clinical trials. We hope they will share our sense of urgency, because PTSD is killing not only our veterans, but also our active duty troops. In January alone, more of our active US military troops died of suicide than were killed in Iraq and Afghanistan wars combined."
Both Dr. Melamede and Richard Cowan, are long-term advocates of the full legalization of marijuana, and support the rights of patients to use the plant to medicate, including smoking. The article reported that support for full legalization is growing rapidly (now up to 44% nationally and a majority in some states).
To view the USA Today article in its entirety, please visit http://www.usatoday.com/news/nation/2010-03-08-marijuana_N.htm to review.
About Cannabis Science, Inc.
Cannabis Science, Inc. is at the forefront of medical marijuana research and development. The Company works with world authorities on phytocannabinoid science targeting critical illnesses, and adheres to scientific methodologies to develop, produce, and commercialize phytocannabinoid-based pharmaceutical products. In sum, we are dedicated to the creation of cannabis-based medicines, both with and without psychoactive properties, to treat disease and the symptoms of disease, as well as for general health maintenance.
Forward Looking Statements; This Press Release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. A statement containing works such as "anticipate," "seek," intend," "believe," "plan," "estimate," "expect," "project," "plan," or similar phrases may be deemed "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Some or all of the events or results anticipated by these forward-looking statements may not occur. Factors that could cause or contribute to such differences include the future U.S. and global economies, the impact of competition, and the Company’s reliance on existing regulations regarding the use and development of cannabis-based drugs. Cannabis Science, Inc. does not undertake any duty nor does it intend to update the results of these forward-looking statements.
CONTACT: Cannabis Science Inc.
Dr. Robert J. Melamede, President & CEO
1-888-889-0888
info@cannabisscience.com
http://www.cannabisscience.com
Peter Glaser
Investor Relations
1-888-889-0888
info@cannabisscience.com
http://www.cannabisscience.com

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s